Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop.
Several important genes that are involved in inflammation and tissue remodeling are switched on by virtue of CRE response elements in their promoters. The upstream signaling mechanisms that inflammatory mediators use to activate cAMP response elements (CREs) are poorly understood. Endothelin (ET) is an important vasoactive mediator that plays roles in inflammation, vascular remodeling, angiogenesis, and carcinogenesis by activating 7 transmembrane G protein-coupled receptors (GPCR). Here we characterized the mechanisms ET-1 uses to regulate CRE-dependent remodeling genes in pulmonary vascular smooth muscle cells. These studies revealed activation pathways involving a cyclooxygenase-2 (COX-2)/prostacyclin receptor (IP receptor) autocrine loop and an interlinked calcium-dependent pathway. We found that ET-1 activated several CRE response genes in vascular smooth muscle cells, particularly COX-2, amphiregulin, follistatin, inhibin-beta-A, and CYR61. ET-1 also activated two other genes epiregulin and HB-EGF. Amphiregulin, follistatin, and inhibin-beta-A and epiregulin were activated by an autocrine loop involving cPLA2, arachidonic acid release, COX-2-dependent PGI(2) synthesis, and IP receptor-linked elevation of cAMP leading to CRE transcription activation. In contrast COX-2, CYR61, and HB-EGF transcription were regulated in a calcium-dependent, COX-2 independent, manner. Observations with IP receptor antagonists and COX-2 inhibitors were confirmed with IP receptor or COX-2-specific small interfering RNAs. ET-1 increases in intracellular calcium and gene transcription were dependent upon ET(a) activation and calcium influx through T type voltage-dependent calcium channels. These studies give important insights into the upstream signaling mechanisms used by G protein-coupled receptor-linked mediators such as ET-1, to activate CRE response genes involved in angiogenesis, vascular remodeling, inflammation, and carcinogenesis.
Deacon
Karl
K
Division of Respiratory Medicine, Centre for Respiratory Research, University of Nottingham, City Hospital Site, Hucknall Road, Nottingham, UK. karl.deacon@nottingham.ac.uk
Knox
Alan J
AJ
D019898:Autocrine Communication / Q000502:physiology*; D002118:Calcium / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000378:metabolism; D019332:Endothelin-1 / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D054467:Phospholipases A2 / Q000378:metabolism; D054510:Phospholipases A2, Cytosolic / Q000378:metabolism; D011651:Pulmonary Artery / Q000166:cytology; D044006:Receptors, Epoprostenol / Q000378:metabolism; D020218:Response Elements / Q000235:genetics; D015854:Up-Regulation; D014652:Vascular Diseases / Q000235:genetics*
D019332:Endothelin-1; D044006:Receptors, Epoprostenol; D000242:Cyclic AMP; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D054467:Phospholipases A2; D054510:Phospholipases A2, Cytosolic; D002118:Calcium
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S348-50
8587411
Br J Pharmacol. 1999 Oct;128(3):721-9
10516654
Nat Rev Mol Cell Biol. 2001 Aug;2(8):599-609
11483993
J Med Chem. 2000 Mar 23;43(6):1041-4
10737736
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S346-7
8587410
Cell Signal. 2004 Dec;16(12):1387-96
15381254
FEBS J. 2007 Jul;274(13):3210-7
17565598
Res Exp Med (Berl). 1997;196(6):327-37
9089881
J Exp Med. 1990 Dec 1;172(6):1741-8
1701822
Eur J Pharmacol. 1992 Apr 10;225(4):347-50
1323478
J Cardiovasc Pharmacol. 1993;22 Suppl 8:S235-8
7509954
J Neurosci. 2001 Nov 15;21(22):8842-53
11698596
Agents Actions Suppl. 1995;45:269-73
7717188
Exp Cell Res. 2003 Mar 10;284(1):2-13
12648462
J Allergy Clin Immunol. 2005 Feb;115(2):287-94
15696083
Biochem Biophys Res Commun. 1989 Jun 30;161(3):1220-7
2662974
Endocrinology. 1993 Feb;132(2):524-9
7678793
Eur J Pharmacol. 1993 Jun 24;237(2-3):275-81
8365455
Br J Pharmacol. 2005 Nov;146(6):903-12
16151434
FEBS Lett. 1997 Jun 23;410(1):22-4
9247115
Biochem Pharmacol. 2002 Aug 1;64(3):425-31
12147293
Br J Pharmacol. 1997 Sep;122(2):217-24
9313928
J Cell Biol. 1993 Aug;122(4):933-40
8349739
J Hum Hypertens. 1992 Dec;6 Suppl 2:S3-8
1289511
J Cell Sci. 2007 Apr 1;120(Pt 7):1256-66
17376964
Mol Hum Reprod. 2006 Oct;12(10):593-9
16888076
Prostaglandins. 1994 Jan;47(1):55-9
8140262
Biochem Biophys Res Commun. 1993 Mar 31;191(3):823-30
8466520
Am J Physiol. 1998 Aug;275(2):L322-9
9700093
Biochem Biophys Res Commun. 1992 Oct 30;188(2):719-26
1280120
Am J Respir Cell Mol Biol. 1995 May;12(5):557-66
7742018
Cancer Res. 2000 Dec 15;60(24):6886-9
11156386
Am J Physiol. 1995 Feb;268(2 Pt 1):L192-200
7864140
Br J Cancer. 2008 Nov 18;99(10):1656-67
18941464
Life Sci. 1998;62(17-18):1485-9
9585123
Front Biosci. 2007 Jan 01;12:1814-32
17127423
Biochem Biophys Res Commun. 2003 Feb 21;301(4):1109-15
12589827
Annu Rev Biochem. 1999;68:821-61
10872467
Nature. 1988 Mar 31;332(6163):411-5
2451132
Heart Vessels. 1993;8(3):121-7
8407721
Int J Cancer. 2006 Jul 1;119(1):49-59
16450371
FEBS J. 2006 Dec;273(23):5479-89
17116246
J Pharmacol Exp Ther. 1994 Dec;271(3):1483-8
7996461
Mol Pharmacol. 1999 May;55(5):902-9
10220569
Prostaglandins Leukot Essent Fatty Acids. 2006 Aug;75(2):81-90
16890416
Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L680-90
12740215
J Clin Invest. 1989 Mar;83(3):1061-5
2522102
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S156-8
8587350
J Biol Chem. 1997 May 30;272(22):14489-96
9162092
Biochem Biophys Res Commun. 2004 Nov 12;324(2):829-34
15474502
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1077-83
18388330
J Neurochem. 2005 May;93(3):664-73
15836625
FASEB J. 2006 Sep;20(11):1936-8
16877529
Trends Cell Biol. 2002 Jun;12(6):258-66
12074885
J Vasc Surg. 1991 Jul;14(1):1-9
2061949
Circ Res. 2005 Apr 29;96(8):864-72
15774856
Biochem Biophys Res Commun. 2007 Mar 23;354(4):885-91
17274952
Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:467-70
2889338
Cell Signal. 2003 Jun;15(6):597-604
12681447
Br J Pharmacol. 2006 Feb;147(3):335-45
16331286
Biochem Pharmacol. 2008 Feb 15;75(4):942-55
18036509